NO20061402L - Anti-tumorformuleringer som omfatter defibrotid alene eller i kombinasjon med andre antitumormidler - Google Patents
Anti-tumorformuleringer som omfatter defibrotid alene eller i kombinasjon med andre antitumormidlerInfo
- Publication number
- NO20061402L NO20061402L NO20061402A NO20061402A NO20061402L NO 20061402 L NO20061402 L NO 20061402L NO 20061402 A NO20061402 A NO 20061402A NO 20061402 A NO20061402 A NO 20061402A NO 20061402 L NO20061402 L NO 20061402L
- Authority
- NO
- Norway
- Prior art keywords
- combination
- antitumor agents
- formulations
- defibrotide
- alone
- Prior art date
Links
- JNWFIPVDEINBAI-UHFFFAOYSA-N [5-hydroxy-4-[4-(1-methylindol-5-yl)-5-oxo-1H-1,2,4-triazol-3-yl]-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(OP(O)(O)=O)C(C(C)C)=CC(C=2N(C(=O)NN=2)C=2C=C3C=CN(C)C3=CC=2)=C1O JNWFIPVDEINBAI-UHFFFAOYSA-N 0.000 title abstract 2
- 230000000259 anti-tumor effect Effects 0.000 title abstract 2
- 229960004120 defibrotide Drugs 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000002246 antineoplastic agent Substances 0.000 title 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001714A ITMI20031714A1 (it) | 2003-09-05 | 2003-09-05 | Formazioni ad azione antitumorale. |
| US53934404P | 2004-01-28 | 2004-01-28 | |
| PCT/EP2004/009723 WO2005023273A1 (en) | 2003-09-05 | 2004-08-27 | Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061402L true NO20061402L (no) | 2006-03-28 |
Family
ID=37064585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061402A NO20061402L (no) | 2003-09-05 | 2006-03-28 | Anti-tumorformuleringer som omfatter defibrotid alene eller i kombinasjon med andre antitumormidler |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US8551967B2 (de) |
| EP (1) | EP1660100B1 (de) |
| JP (1) | JP4671962B2 (de) |
| KR (1) | KR20060061367A (de) |
| CN (1) | CN100490820C (de) |
| AT (1) | ATE399558T1 (de) |
| AU (1) | AU2004269896B2 (de) |
| BR (1) | BRPI0414114A (de) |
| CA (1) | CA2537226C (de) |
| DE (1) | DE602004014787D1 (de) |
| DK (1) | DK1660100T3 (de) |
| ES (1) | ES2308223T3 (de) |
| IL (1) | IL173785A0 (de) |
| IS (1) | IS8334A (de) |
| IT (1) | ITMI20031714A1 (de) |
| MX (1) | MXPA06002489A (de) |
| NO (1) | NO20061402L (de) |
| PT (1) | PT1660100E (de) |
| RS (1) | RS20060154A (de) |
| RU (1) | RU2348413C2 (de) |
| UA (1) | UA83500C2 (de) |
| WO (1) | WO2005023273A1 (de) |
| ZA (1) | ZA200601852B (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006222045B2 (en) * | 2005-03-03 | 2011-10-20 | Gentium Spa | Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors |
| EP1872787A1 (de) * | 2006-06-27 | 2008-01-02 | Gentium S.p.A. | Verwendung von Defibrotide als Heparanasehemmer |
| EP2103689A1 (de) * | 2008-03-19 | 2009-09-23 | Gentium S.p.A. | Synthetische Phosphodiester-Oligonukleotide und deren therapeutische Verwendungen |
| ES2694239T3 (es) | 2010-11-12 | 2018-12-19 | Gentium S.R.L. | Defibrótido para su uso en profilaxis y/o tratamiento de la enfermedad de Injerto contra huésped (GVHD) |
| RU2627177C2 (ru) | 2012-06-22 | 2017-08-03 | Джентиум С.Р.Л. | Способ определения биологической активности дефибротида, основанный на применении эуглобулина |
| EP3026122A1 (de) | 2014-11-27 | 2016-06-01 | Gentium S.p.A. | Zellenbasiertes Verfahren zur Bestimmung der Wirksamkeit von Defibrotid |
| US10380734B2 (en) * | 2017-02-27 | 2019-08-13 | Aniket Bharat Parikh | System, method and computer program product for security analysis of jewelry items |
| WO2019028340A1 (en) * | 2017-08-03 | 2019-02-07 | Jazz Pharmaceuticals Ireland Limited | FORMULATIONS COMPRISING A HIGH CONCENTRATION NUCLEIC ACID |
| US11571440B2 (en) | 2018-04-12 | 2023-02-07 | Jazz Pharmaceuticals Ireland Limited | Defibrotide for the prevention and treatment of cytokine release syndrome and neurotoxicity associated with immunodepletion |
| WO2020118165A1 (en) | 2018-12-07 | 2020-06-11 | Jazz Pharmaceuticals Ireland Limited | Subcutaneous delivery of high concentration formulations |
| EP4110287A1 (de) | 2020-02-28 | 2023-01-04 | Jazz Pharmaceuticals Ireland Limited | Abgabe von niedrigviskosen formulierungen |
| TW202308659A (zh) | 2021-05-06 | 2023-03-01 | 愛爾蘭商爵士製藥愛爾蘭有限責任公司 | 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3899481A (en) * | 1970-11-03 | 1975-08-12 | Crinos Industria Farmaco | Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs |
| IT1043823B (it) * | 1970-11-03 | 1980-02-29 | Prephar | Procedimento per l estrazione di acidi nucleici da organi animali |
| DE2154279A1 (de) * | 1970-11-03 | 1972-05-25 | Crinos Industria Farmaco | Medikamente für das fibrinolytische System |
| US4853221A (en) * | 1980-11-13 | 1989-08-01 | Warner-Lambert Company | Method for treating non-small cell lung cancer, head and neck cancers and breast cancer |
| IT1170214B (it) * | 1983-09-12 | 1987-06-03 | Crinos Industria Farmaco | Composizione farmaceutica per la cura delle arteriopatie periferiche |
| IT1206341B (it) * | 1984-02-16 | 1989-04-14 | Crinos Industria Farmaco | Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio. |
| US4694134A (en) * | 1985-05-28 | 1987-09-15 | Ajax Magnethermic Corporation | Apparatus for overheating edges of skelp for the production of compression welded pipe |
| IT1190313B (it) * | 1986-04-17 | 1988-02-16 | Crinos Industria Farmaco | Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante |
| US5223609A (en) * | 1986-04-17 | 1993-06-29 | Crinos Industria Farmacobiologica S.P.A. | Process for obtaining chemically defined and reproducible polydeoxyribonucleotides |
| US6699985B2 (en) * | 1991-08-21 | 2004-03-02 | Arsinur Burcoglu | Method of treating HIV infection and related secondary infections thereof |
| US5977083A (en) * | 1991-08-21 | 1999-11-02 | Burcoglu; Arsinur | Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states |
| IT1252174B (it) * | 1991-12-09 | 1995-06-05 | Crinos Industria Farmaco | Oligodesossimibonucleotidi ad attivita' antiischemica e procedimenti per il loro ottenimento |
| DE9202745U1 (de) | 1992-03-02 | 1992-04-30 | Howmedica Gmbh, 2314 Schoenkirchen | Vorrichtung zum Verspannen von Wirbeln der menschlichen Wirbelsäule |
| US5578716A (en) * | 1993-12-01 | 1996-11-26 | Mcgill University | DNA methyltransferase antisense oligonucleotides |
| EP1202750A4 (de) * | 1997-04-28 | 2002-10-16 | Arsinur Burcoglu | Verfahren zur behandlung von hiv-infektionen und von deren opportunistischen infektionen |
| AU8125098A (en) | 1997-05-30 | 1998-12-30 | Mcgill University | Dna methyltransferase genomic sequences and antisense oligonucleotides |
| US6177545B1 (en) | 1997-09-02 | 2001-01-23 | Insight Strategy & Marketing Ltd. | Heparanase specific molecular probes and their use in research and medical applications |
| DE19740384A1 (de) | 1997-09-08 | 1999-03-11 | Max Delbrueck Centrum | Antisense Oligodesoxynukleotide (ODN) gegen Proteinkinase C (PKC)-Isoformen, ihre Verwendung und pharmazeutische Zubereitungen dieser ODN |
| WO2000074634A2 (en) * | 1999-06-03 | 2000-12-14 | Au Jessie L S | Methods and compositions for modulating cell proliferation and cell death |
| HUP0700079A2 (en) * | 2000-12-29 | 2007-05-02 | Savient Pharmaceuticals | Isolated molecules comprising epitopes containing sulfated moieties, antibodies to such epitopes, and uses thereof |
| US6770753B2 (en) | 2001-07-05 | 2004-08-03 | The Trustees Of Columbia University In The City Of New York | Phosphorothioate antisense heparanase oligonucleotides |
| WO2003027313A2 (en) | 2001-09-24 | 2003-04-03 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| US20050032882A1 (en) * | 2002-03-06 | 2005-02-10 | Sophie Chen | Botanical extract compositions and methods of use |
| UA83628C2 (ru) * | 2002-05-31 | 2008-08-11 | Клиникум Дер Универзитет Регенсбург | Способ защиты эндотелиальных и эпителиальных клеток во время трансплантации алогенных стволовых клеток |
| MXPA05000272A (es) * | 2002-07-01 | 2005-09-20 | Savient Pharmaceuticals Inc | Anticuerpos y usos de ellos. |
| EP1550462B1 (de) | 2002-08-06 | 2012-01-25 | Toray Industries, Inc. | Mittel zur behandlung oder prävention von nierenerkrankungen und verfahren zur diagnose von nierenerkrankungen |
| DE10244453A1 (de) | 2002-09-24 | 2004-04-01 | Phenomiques Gmbh | Hemmung der Proteinkinase C-alpha zur Behandlung von Krankheiten |
| US7803781B2 (en) | 2003-02-28 | 2010-09-28 | Isis Pharmaceuticals, Inc. | Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| AU2006222045B2 (en) | 2005-03-03 | 2011-10-20 | Gentium Spa | Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors |
| EP1872787A1 (de) | 2006-06-27 | 2008-01-02 | Gentium S.p.A. | Verwendung von Defibrotide als Heparanasehemmer |
| EP1982722A1 (de) | 2007-04-16 | 2008-10-22 | Gentium S.p.A. | Verwendung von Oligotid zur Behandlung von Nierenerkrankungen |
-
2003
- 2003-09-05 IT IT001714A patent/ITMI20031714A1/it unknown
-
2004
- 2004-08-27 MX MXPA06002489A patent/MXPA06002489A/es active IP Right Grant
- 2004-08-27 RU RU2006109210/15A patent/RU2348413C2/ru not_active IP Right Cessation
- 2004-08-27 CA CA2537226A patent/CA2537226C/en not_active Expired - Fee Related
- 2004-08-27 WO PCT/EP2004/009723 patent/WO2005023273A1/en not_active Ceased
- 2004-08-27 ES ES04764686T patent/ES2308223T3/es not_active Expired - Lifetime
- 2004-08-27 PT PT04764686T patent/PT1660100E/pt unknown
- 2004-08-27 EP EP04764686A patent/EP1660100B1/de not_active Expired - Lifetime
- 2004-08-27 UA UAA200602374A patent/UA83500C2/uk unknown
- 2004-08-27 AT AT04764686T patent/ATE399558T1/de active
- 2004-08-27 JP JP2006525096A patent/JP4671962B2/ja not_active Expired - Fee Related
- 2004-08-27 DE DE602004014787T patent/DE602004014787D1/de not_active Expired - Lifetime
- 2004-08-27 CN CNB2004800253315A patent/CN100490820C/zh not_active Expired - Fee Related
- 2004-08-27 ZA ZA200601852A patent/ZA200601852B/en unknown
- 2004-08-27 RS YUP-2006/0154A patent/RS20060154A/sr unknown
- 2004-08-27 BR BRPI0414114-8A patent/BRPI0414114A/pt not_active IP Right Cessation
- 2004-08-27 AU AU2004269896A patent/AU2004269896B2/en not_active Ceased
- 2004-08-27 DK DK04764686T patent/DK1660100T3/da active
- 2004-08-27 KR KR1020067004451A patent/KR20060061367A/ko not_active Withdrawn
-
2006
- 2006-02-16 IL IL173785A patent/IL173785A0/en unknown
- 2006-02-28 IS IS8334A patent/IS8334A/is unknown
- 2006-03-02 US US11/366,243 patent/US8551967B2/en not_active Expired - Fee Related
- 2006-03-28 NO NO20061402A patent/NO20061402L/no not_active Application Discontinuation
-
2013
- 2013-09-06 US US14/019,674 patent/US20140005256A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN100490820C (zh) | 2009-05-27 |
| IL173785A0 (en) | 2006-07-05 |
| DK1660100T3 (da) | 2008-11-10 |
| ITMI20031714A1 (it) | 2005-03-06 |
| RU2348413C2 (ru) | 2009-03-10 |
| RS20060154A (sr) | 2008-08-07 |
| CA2537226C (en) | 2016-05-03 |
| ATE399558T1 (de) | 2008-07-15 |
| DE602004014787D1 (de) | 2008-08-14 |
| WO2005023273A1 (en) | 2005-03-17 |
| US20140005256A1 (en) | 2014-01-02 |
| UA83500C2 (uk) | 2008-07-25 |
| JP2007504194A (ja) | 2007-03-01 |
| AU2004269896A1 (en) | 2005-03-17 |
| CA2537226A1 (en) | 2005-03-17 |
| IS8334A (is) | 2006-02-28 |
| ZA200601852B (en) | 2007-06-27 |
| RU2006109210A (ru) | 2007-10-10 |
| MXPA06002489A (es) | 2006-06-20 |
| PT1660100E (pt) | 2008-10-14 |
| CN1845746A (zh) | 2006-10-11 |
| AU2004269896B2 (en) | 2009-11-19 |
| US8551967B2 (en) | 2013-10-08 |
| KR20060061367A (ko) | 2006-06-07 |
| JP4671962B2 (ja) | 2011-04-20 |
| ES2308223T3 (es) | 2008-12-01 |
| US20060211646A1 (en) | 2006-09-21 |
| EP1660100B1 (de) | 2008-07-02 |
| BRPI0414114A (pt) | 2006-10-31 |
| EP1660100A1 (de) | 2006-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITMI20041550A1 (it) | Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide | |
| AR050616A1 (es) | Composiciones farmaceuticas para el tratamiento de trastornos hiperproliferativos. | |
| IL211084A0 (en) | Single use module | |
| IL186104A0 (en) | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer | |
| DK1689724T3 (da) | Quinazolinonforbindelser som anticancermidler | |
| PT1411908E (pt) | Tratamento de infeccoes da unha com no | |
| ITMI20052171A1 (it) | Composti e-amminocarbonil bicicloepten pirimidindiamminici stereoisomericamente arricchiti e loro uso | |
| NO20061402L (no) | Anti-tumorformuleringer som omfatter defibrotid alene eller i kombinasjon med andre antitumormidler | |
| NO20073026L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamider, fremstilling og sammensetninger derav samt anvendelse derav | |
| EP1453525A4 (de) | Selektives targeting von apoptotischen zellen | |
| NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
| ITMI20031396A1 (it) | Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante. | |
| ATE373504T1 (de) | Avermectinen oder milbemycine und bis-aryl- derivate enthaltende anthelminthische zusammensetzungen | |
| NL1026201A1 (nl) | Heterodyne bundelafgifte met actieve sturing van twee orthogonale polarisaties. | |
| WO2005000204A3 (en) | Pancreatic cancer treatment | |
| TR200302134T4 (tr) | 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. | |
| NO20065791L (no) | Asyklovir-formuleringer | |
| BRPI0417513A (pt) | agentes combinados de chp-gemcitabina e seu uso como substáncias antitumorais ativas | |
| ATE410154T1 (de) | Pharmazeutische zusammensetzung enthaltend 2,4- dichlorbenzylalkohol und amylmetakresol | |
| NO20052954D0 (no) | Diterpenoidforbindelser, sammensetninger derav og deres anvendelse som anti-cancer eller anti-fungale midler | |
| WO2005039484A3 (en) | Indolocarbazole anticancer agents and methods of using same | |
| AU4344202A (en) | Indolocarbazole anticancer agents and methods of using them | |
| WO2007081365A3 (en) | Multiple antigenic agents and methods for using the same | |
| ITRM20030219A1 (it) | Uso della liquerizia per la prevenzione e la cura di aids e sars. | |
| ATE301667T1 (de) | Anthracyclinglykosid-14-sulfon säurederivate mit antitumorwirkung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |